Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Feb. 7, 2019

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Leading patient, professional organizations announce funding to improve communications, address IBD shared decision-making

April 17, 2018

Funding recipients will address ways to improve shared decision-making and effective health communications.

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

The Development and Approval of Inflectra, a Biosimilar to Remicade: Case Presentation

April 3, 2018

In this on-demand webinar, Sue Lim, MD of the FDA provides a general review of the requirements for a biosimilar 351(k) application and discusses the approval process for Inflectra.

APPs: Enhance your delivery of patient care

March 28, 2018

AGA's popular course for advanced practice providers will be held this summer in Chicago.

CMS announces infliximab biosimilar coding changes

March 26, 2018

Effective April 1, codes are available to identify specific versions of the biosimilar administered.
Advertisement

Best Practices in IBD: Differential Diagnosis

March 15, 2018

This activity outlines the different pathophysiologic processes and symptoms that differentiate IBD and from functional bowel disorders such as IBS, and it reviews AGA’s Crohn's disease and ulcerative colitis “Clinical Care Pathways.”

Save the date for the 2019 Crohn's & Colitis Congress

March 15, 2018

Build a powerful network with IBD thought-leaders and discover cutting-edge research at the Bellagio in Las Vegas Feb. 7-9, 2019.

Blog: What Happens When Patients With Crohn’s Disease in Remission Stop Taking Infliximab?

Feb. 21, 2018

Researchers report that fewer than one-fifth of patients required surgery. Read more on the AGA Journals Blog.

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Building an IBD Specialty Clinic from the Ground Up

Feb. 7, 2018

Gastro One in Tennessee developed an IBD clinic within their practice, which decreased emergency room visits by 70 percent.

4 New & Noteworthy IBD Drug Studies

Jan. 30, 2018

We recommend reviewing these four abstracts from the Crohn’s & Colitis Congress to keep informed on IBD treatment options.

6 Takeaways from the Crohn’s & Colitis Congress Poster Hall

Jan. 24, 2018

These studies represent the latest advances in inflammatory bowel disease (IBD) research and patient care.

Tell Congress: Protect the Care of and Research for Digestive Disease Patients

Jan. 23, 2018

Join AGA Virtual Advocacy Day — Thursday, Jan. 25.

AGA Launches New Patient App to Aid in IBD Monitoring and Education

Jan. 23, 2018

Digital offerings designed to enhance IBD care and shared decision making between patients and physicians.

Beyond Drugs for IBD: Improving the Overall Health of IBD Patients

Jan. 19, 2018

Actionable IBD research to be presented at the Crohn’s & Colitis Congress™

New Strategies to Improve the Quality of Inflammatory Bowel Disease (IBD) Care

Jan. 19, 2018

Innovative IBD research to be presented at the Crohn’s & Colitis Congress™

New Drugs for Inflammatory Bowel Disease (IBD)

Jan. 19, 2018

Breakthrough IBD research to be presented at the Crohn’s & Colitis Congress™

Compendium of AGA 2017 Clinical Guidance

Dec. 21, 2017

Are you up-to-date on AGA's latest clinical guidance?

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Insurance Barriers Should Not Hinder Step Therapy Treatment for IBD

Dec. 13, 2017

AGA participated in a congressional briefing to highlight the need for physician use of step therapy treatment without barriers.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.

Healing of Tonsillar Crohn’s Disease With Infliximab

Oct. 22, 2017